UTI Inc (179900) — Cash Flow Reinvestment Rate

Latest as of December 2023: 1.99x

UTI Inc (179900) has a Cash Flow Reinvestment Rate of 1.99x as of December 2023, reinvesting ₩3.86 Billion (capex ₩3.53 Billion plus investments ₩-328.77 Million) from operating cash flow of ₩1.94 Billion. See UTI Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.99x
(Capex + Investments) / Operating CF

Total Reinvested

₩3.86 Billion
Capex + Investments

Operating Cash Flow

₩1.94 Billion
KRW

Capital Expenditures

₩3.53 Billion
KRW

UTI Inc Cash Flow Reinvestment Rate (2016–2022)

Historical reinvestment intensity for UTI Inc across 7 annual periods. For the full cash flow conversion analysis, see 179900 cash flow metrics.

Annual Cash Flow Reinvestment Rate for UTI Inc (2016–2022)

Year-by-year capital reinvestment analysis for UTI Inc. See UTI Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 7.94x ₩25.01 Billion ₩3.15 Billion ₩5.18 Billion ▲ +830.5%
2021 0.85x ₩4.92 Billion ₩5.76 Billion ₩4.40 Billion ▼ -79.2%
2020 4.10x ₩16.79 Billion ₩4.09 Billion ₩12.29 Billion ▲ +261.0%
2019 1.14x ₩14.35 Billion ₩12.62 Billion ₩12.20 Billion ▼ -11.8%
2018 1.29x ₩12.43 Billion ₩9.65 Billion ₩11.74 Billion ▲ +11.0%
2017 1.16x ₩8.21 Billion ₩7.07 Billion ₩4.71 Billion ▲ +1024.4%
2016 0.10x ₩1.45 Billion ₩14.01 Billion ₩1.31 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow